Cargando…

Optimizing molecular residual disease detection using liquid biopsy postoperatively in early stage lung cancer

Detalles Bibliográficos
Autores principales:	McGuire, Anna L, Hughesman, Curtis B, McConechy, Melissa K, Melosky, Barb, Lam, Stephen, Myers, Renelle, Yee, John, Tang, Ernest, Yip, Stephen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Future Medicine Ltd 2020
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7186850/ https://www.ncbi.nlm.nih.gov/pubmed/32346401 http://dx.doi.org/10.2217/lmt-2019-0017

Ejemplares similares

The Clinically Actionable Molecular Profile of Early versus Late-Stage Non-Small Cell Lung Cancer, an Individual Age and Sex Propensity-Matched Pair Analysis
por: McGuire, Anna L., et al.
Publicado: (2022)

Improving Time-to-Treatment for Advanced Non-Small Cell Lung Cancer Patients through Faster Single Gene EGFR Testing Using the Idylla™ EGFR Testing Platform
por: Banyi, Norbert, et al.
Publicado: (2022)

Acute organ injury is associated with alterations in the cell-free plasma transcriptome
por: Boyd, John H, et al.
Publicado: (2014)

Low-dose vasopressin infusion results in increased mortality and cardiac dysfunction following ischemia-reperfusion injury in mice
por: Indrambarya, Toonchai, et al.
Publicado: (2009)

Disparate Time-to-Treatment and Varied Incidence of Actionable Non-Small Cell Lung Cancer Molecular Alterations in British Columbia: A Historical Cohort Study
por: Hilzenrat, Roy Avraham, et al.
Publicado: (2022)

Steroid Hormone Control of Cell Death and Cell Survival: Molecular Insights Using RNAi
por: Chittaranjan, Suganthi, et al.
Publicado: (2009)

Feasibility of combined optical coherence tomography and autofluorescence imaging for visualization of needle biopsy placement
por: Hohert, Geoffrey, et al.
Publicado: (2020)

Quantitative Profiling of Single Formalin Fixed Tumour Sections: proteomics for translational research
por: Hughes, Christopher S., et al.
Publicado: (2016)

Biopsying Diabetics … How Risky Is It?
por: Taliercio, Jonathan J., et al.
Publicado: (2021)

Liquid biopsies and minimal residual disease in myeloid malignancies
por: Allam, Sabine, et al.
Publicado: (2023)

Liquid biopsies and minimal residual disease in lymphoid malignancies
por: Bou Zerdan, Maroun, et al.
Publicado: (2023)

Intratumoral heterogeneity in a minority of ovarian low-grade serous carcinomas
por: Tone, Alicia A, et al.
Publicado: (2014)

Liquid Biopsy to Detect Minimal Residual Disease: Methodology and Impact
por: Honoré, Natasha, et al.
Publicado: (2021)

The Minimal Residual Disease Using Liquid Biopsies in Hematological Malignancies
por: Colmenares, Rafael, et al.
Publicado: (2022)

The ability of cancer-specific and generic preference-based instruments to discriminate across clinical and self-reported measures of cancer severities
por: Teckle, Paulos, et al.
Publicado: (2011)

Mapping the FACT-G cancer-specific quality of life instrument to the EQ-5D and SF-6D
por: Teckle, Paulos, et al.
Publicado: (2013)

Epigenetic liquid biopsies for minimal residual disease, what’s around the corner?
por: Johnston, Andrew D., et al.
Publicado: (2023)

First-line osimertinib for patients with EGFR-mutated advanced non-small cell lung cancer: efficacy and safety during the COVID-19 pandemic
por: Lakkunarajah, Suganija, et al.
Publicado: (2023)

MEDB-74. Serial assessment of measurable residual disease in medulloblastoma liquid biopsies
por: Northcott, Paul, et al.
Publicado: (2022)

Liquid biopsy and blood-based minimal residual disease evaluation in multiple myeloma
por: GOZZETTI, ALESSANDRO, et al.
Publicado: (2023)

EGFR circulating tumour DNA testing: identification of predictors of ctDNA detection and implications for survival outcomes
por: Pender, Alexandra, et al.
Publicado: (2020)

Very high and low residual spenders in private health insurance markets: Germany, The Netherlands and the U.S. Marketplaces
por: McGuire, Thomas G., et al.
Publicado: (2020)

Health and Budget Impact of Liquid-Biopsy-Based Comprehensive Genomic Profile (CGP) Testing in Tissue-Limited Advanced Non-Small Cell Lung Cancer (aNSCLC) Patients
por: Patel, Yuti P., et al.
Publicado: (2021)

Can We “Up Our Game” in Bronchoscopy Procedural Training?
por: Myers, Renelle, et al.
Publicado: (2020)

Physiological Responses During Multiplay Exergaming in Young Adult Males are Game-Dependent
por: McGuire, Stephen, et al.
Publicado: (2015)

Evaluation of endometrial carcinoma prognostic immunohistochemistry markers in the context of molecular classification
por: Karnezis, Anthony N, et al.
Publicado: (2017)

In‐depth molecular profiling of the biphasic components of uterine carcinosarcomas
por: McConechy, Melissa K, et al.
Publicado: (2015)

Breath testing for SARS-CoV-2 infection
por: Myers, Renelle, et al.
Publicado: (2023)

Prior Evictions Among People Experiencing Homelessness in Delaware
por: Metraux, Stephen, et al.
Publicado: (2022)

Interpretation of somatic POLE mutations in endometrial carcinoma
por: León‐Castillo, Alicia, et al.
Publicado: (2020)

Redefining precision radiotherapy through liquid biopsy
por: McLaren, D. B., et al.
Publicado: (2023)

Liquid Biopsy: A Biomarker-Driven Tool towards Precision Oncology
por: Yee, Nelson S.
Publicado: (2020)

AN ASSAY FOR INTERCELLULAR ADHESIVE SPECIFICITY
por: Roth, Stephen, et al.
Publicado: (1971)

EVIDENCE FOR CELL-SURFACE GLYCOSYLTRANSFERASES : Their Potential Role in Cellular Recognition
por: Roth, Stephen, et al.
Publicado: (1971)

Liquid biopsy for minimal residual disease detection in leukemia using a portable blast cell biochip
por: Khoo, Bee Luan, et al.
Publicado: (2019)

Comprehensive liquid biopsy analysis as a tool for the early detection of minimal residual disease in breast cancer
por: Stergiopoulou, Dimitra, et al.
Publicado: (2023)

Liquid biopsy in lymphoma
por: Rossi, Davide, et al.
Publicado: (2019)

Liquid Biopsy in Glioblastoma
por: Ronvaux, Lorian, et al.
Publicado: (2022)

Liquid biopsy and glioblastoma
por: Eibl, Robert H., et al.
Publicado: (2023)

Systematic analysis of somatic mutations impacting gene expression in 12 tumour types
por: Ding, Jiarui, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_5f2bdnsmt4estam09n0145tn4a